Vivek Mittal

Scientist, New Yorker, Weill Cornell Medical Center. Cancer Biologist, Lung and Breast cancer basic and translational research. Views are my own.

[Eric Topol @EricTopol]

The ramp up of cancer immunotherapy is remarkable. Now we're seeing vaccines achieve some cures or remissions in the most refractory cancers: pancreatic, melanoma, glioblastoma, renal, triple-negative breast cancer.
✓ out the new Ground Truths (link in profile)

[Vivek Mittal @mittallab]

@Aiims1742 congrats anirban.

[Vivek Mittal @mittallab]

@Acyn He is comfortable in Shark Tank. Has no clue about geopolitics. Best off in his lane

[Vivek Mittal @mittallab]

@MocklerHQ @adammocklerr @GeraldoRivera rivera needs to adjust to the next gen.

[Vivek Mittal @mittallab]

RIP. Greg Hannon.

[Charles Swanton @CharlesSwanton]

People often ask how breakthroughs occur in cancer biology-often the story is more complex - the survival plot for myeloma outcomes is extraordinary - improvements come about in incremental steps - in my lifetime treatment of Myeloma has almost transformed into a curable disease

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

A tumor-derived metabolite primes the leptomeningeal pre-metastatic niche

https://t.co/rU7nkxVe2H

[CAP-IT @NCICAPIT]

Final call to register for the March 30 CAP-IT Summit!
https://t.co/UUubLYtcpq

Don’t miss the opportunity to engage with leaders in cancer prevention and interception.

[Vivek Mittal @mittallab]

@IrenemGhobrial @luciaborriell @NCI Great talk Irene. What as amazing body of work on myeloma.

[Vivek Mittal @mittallab]

Yongfeng He presenting our vaccine work at NCI. @NCICAPIT @WCM_CTSurgery @WCM_MeyerCancer

[CAP-IT @NCICAPIT]

The three CAP-IT U54 centers presented updates on their research progress. Drs. Vivek Mittal @mittallab and Julie Magarian Blander of @WeillCornell highlighted efforts from the CAP-IT Center for LNP nucleic acid cancer immunoprevention.

[Weill Cornell Medicine Cardiothoracic Surgery @WCM_CTSurgery]

@WCM is studying new treatments for non-small cell lung cancer (IB–III N2).
Compare chemo + immunotherapy vs radiation + immunotherapy.
✅ Age 18+, potentially resectable disease.
📞 [email protected] | 212-746-5156
IRB #24-02027124
Learn more & see if you qualify!

[Vivek Mittal @mittallab]

@bennyjohnson you are joke

[Vivek Mittal @mittallab]

@Aiims1742 @Perlmutter_CC @nyulangone @JohnPLeonardMD @nyugrossman @NYULangoneLI @NYULangoneBK @DrOscarLahoud @EmelineAvikiMD congrats. great news

[CAP-IT @NCICAPIT]

At today’s #CAPITSCMeeting, we were honored to be joined by two patient advocates: Ms. Robin Beth Dubin from @Alive_And_Kickn and Ms. Erica Kirschner from @LFSAssociation. Their powerful stories and perspectives deeply moved us and reinforced the importance of CAP-IT’s mission to discover molecularly and immunologically targeted agents to prevent or intercept cancer in high-risk populations.

Dr. Margie Clapper of @FoxChaseCancer, Chair of the Resource Sharing Working Group, shared updates on WG activities, including development of a searchable shared resource catalog with technical assistance from the CAP-IT DRCC team at @RoswellPark.

Dr. Yongfeng He @YongfengHe_PhD from @mittallab of @WeillCornell U54 presented updates on their LNP mRNA vaccine project aimed at intercepting the progression from pre-invasive to invasive lung cancer, sparking strong interest and discussion.

[Daisuke Kotani, MD, Ph.D 小谷 大輔 @DaisukeKotani]

The Role of PD-1 in Maintaining Stem-like CD8+ T Cells @Nature
✅PD-1 doesn’t just “brake” — it fine-tunes TCR signaling to prevent exhaustion of precious stem-like CD8+ T cells
✅Blocking PD-1 can depletes these stem-like progenitors
👉PD-1 might be less an off-switch and more a quality controller for long-term T cell immunity
https://t.co/g9uPBSjOm1
@OncoAlert

[Cancer Grand Challenges @CancerGrand]

What if a cancer-causing mutation were less like a ticking time bomb and more like an actor waiting for the right opportunity? Team SPECIFICANCER’s brand new paper gives us an insight.

The new paper from SPECIFICANCER, published in @Nature, reveals that it’s not just the mutation that matters — it’s where in the liver that mutation appears. Understanding which cells can turn cancerous — and why — helps us better predict risk and develop smarter, more targeted treatments.

Congratulations to the #CancerGrandChallenges SPECIFICANCER team (co-funded by @TheMarkFdn). This work was led by Owen Sansom and Future Leader Alex Raven.

👉 Read more from Alex: https://t.co/L4dpfswgRn

#CancerResearch

[Vivek Mittal @mittallab]

@Eman856 @RpsAgainstTrump why

[Vivek Mittal @mittallab]

So gratifying to see state-of-the art cancer research laboratory dedicated to discovering next generation cancer vaccines @CrestTcg . As a founding member and scientific advisor it’s exciting to see this vision come to life https://t.co/XBn8UDWy8D. https://t.co/P8CnQpb7Wv

[Vivek Mittal @mittallab]

@ElizSMcKenna Great Wall is such an amazing experience
Enjoy